These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9930074)

  • 1. The prognostic significance of beta human chorionic gonadotrophin and its metabolites in women with cervical carcinoma.
    Crawford RA; Iles RK; Carter PG; Caldwell CJ; Shepherd JH; Chard T
    J Clin Pathol; 1998 Sep; 51(9):685-8. PubMed ID: 9930074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary chorionic gonadotropin subunits and beta-core in nonpregnant women. A study of benign and malignant gynecologic disorders.
    Neven P; Iles RK; Lee CL; Hudson CN; Shepherd JH; Chard T
    Cancer; 1993 Jun; 71(12):4124-30. PubMed ID: 7685240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of urinary beta core fragment of human chorionic gonadotrophin in women with vulvovaginal malignancy and its prognostic significance.
    Carter PG; Iles RK; Neven P; Ind TE; Shepherd JH; Chard T
    Br J Cancer; 1995 Feb; 71(2):350-3. PubMed ID: 7530986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Twist enhances risk of poor oncologic outcome in patients with stage Ib to II cervical carcinoma with lymphovascular space involvement.
    Kajiyama H; Shibata K; Umezu T; Mizuno M; Suzuki S; Yamamoto E; Fujiwara S; Kikkawa F
    Hum Pathol; 2013 Feb; 44(2):181-8. PubMed ID: 22974479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
    Okazawa M; Mabuchi S; Isohashi F; Suzuki O; Yoshioka Y; Sasano T; Ohta Y; Kamiura S; Ogawa K; Kimura T
    Int J Gynecol Cancer; 2013 Mar; 23(3):567-75. PubMed ID: 23385284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of progression-free survival and response to paclitaxel plus carboplatin in patients with recurrent or advanced cervical cancer.
    Hisamatsu T; Mabuchi S; Yoshino K; Fujita M; Enomoto T; Hamasaki T; Kimura T
    Int J Gynecol Cancer; 2012 May; 22(4):623-9. PubMed ID: 22343974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors and adjuvant therapy on survival in early-stage cervical adenocarcinoma/adenosquamous carcinoma after primary radical surgery: A Taiwanese Gynecologic Oncology Group (TGOG) study.
    Twu NF; Ou YC; Liao CI; Chang WY; Yang LY; Tang YH; Chen TC; Chen CH; Chen TH; Yeh LS; Hsu ST; Chen YC; Chang CC; Cheng YM; Huang CY; Liu FS; Lin YS; Hsiao SM; Kan YY; Lai CH
    Surg Oncol; 2016 Sep; 25(3):229-35. PubMed ID: 27566027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary concentration of human chorionic gonadotrophin and its fragments as a prognostic marker in bladder cancer.
    Iles RK; Persad R; Trivedi M; Sharma KB; Dickinson A; Smith P; Chard T
    Br J Urol; 1996 Jan; 77(1):61-9. PubMed ID: 8653319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma.
    Farley JH; Hickey KW; Carlson JW; Rose GS; Kost ER; Harrison TA
    Cancer; 2003 May; 97(9):2196-202. PubMed ID: 12712471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic significance of urinary beta core fragment in premenopausal women with carcinoma of the cervix.
    Carter PG; Iles RK; Neven P; Ind TE; Shepherd JH; Chard T
    Gynecol Oncol; 1994 Nov; 55(2):271-6. PubMed ID: 7525427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan.
    Chen RJ; Lin YH; Chen CA; Huang SC; Chow SN; Hsieh CY
    Gynecol Oncol; 1999 May; 73(2):184-90. PubMed ID: 10329032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinoma.
    Yokoi E; Mabuchi S; Takahashi R; Matsumoto Y; Kuroda H; Kozasa K; Kimura T
    J Gynecol Oncol; 2017 Mar; 28(2):e19. PubMed ID: 28028992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of serum and immunohistochemical expression of SCC and CA19-9 in radiation therapy for cervical cancer.
    Abe A; Nakano T; Morita S; Oka K
    Anticancer Res; 1999; 19(1B):829-36. PubMed ID: 10216501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Importance of the Site of Recurrence in Patients With Metastatic Recurrent Cervical Cancer.
    Kim TH; Kim MH; Kim BJ; Park SI; Ryu SY; Cho CK
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1124-1131. PubMed ID: 28721896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High levels of soluble MICA are significantly related to increased disease-free and disease-specific survival in patients with cervical adenocarcinoma.
    Samuels S; Ferns DM; Meijer D; van Straalen JP; Buist MR; Zijlmans HJ; Kenter GG; Jordanova ES
    Tissue Antigens; 2015 Jun; 85(6):476-83. PubMed ID: 25871737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. beta hCG as a prognostic marker in adenocarcinoma of the prostate.
    Sheaff MT; Martin JE; Badenoch DF; Baithun SI
    J Clin Pathol; 1996 Apr; 49(4):329-32. PubMed ID: 8655711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of Erb-b2 immunostaining in cervical cancer.
    Nevin J; Laing D; Kaye P; McCulloch T; Barnard R; Silcocks P; Blackett T; Paterson M; Sharp F; Cruse P
    Gynecol Oncol; 1999 Jun; 73(3):354-8. PubMed ID: 10366459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
    Kim YB; Kim GE; Pyo HR; Cho NH; Keum KC; Lee CG; Seong J; Suh CO; Park TK
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):822-9. PubMed ID: 15465199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved prognostic value of 18F-FDG PET using a simple visual analysis of tumor characteristics in patients with cervical cancer.
    Miller TR; Pinkus E; Dehdashti F; Grigsby PW
    J Nucl Med; 2003 Feb; 44(2):192-7. PubMed ID: 12571208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of clinicopathological significance, BIRC7, and STC2 expression between squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder.
    Yuan Y; Yang ZL; Zou Q; Li JH; Li DQ; Liang LF; Zeng GX; Chen SL
    Neoplasma; 2013; 60(6):698-705. PubMed ID: 23906305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.